Subscribe to Vendors

Vendors

CD&R pulls trigger on Drive

 - 
08/30/2016

NEW YORK – Clayton, Dubilier & Rice will make a “significant equity investment” in Drive DeVilbiss Healthcare, the companies announced today.

CD&R will make the investment, “alongside existing management,” according to a press release.

ResMed: ‘We’re committed to compliance’

 - 
08/26/2016

SAN DIEGO – Will ResMed become the second major manufacturer to get a slap on the wrist from the government for its resupply program?

Cure Medical embraces new role as innovator

 - 
08/26/2016

NEWPORT BEACH, Calif. – Cure Medical’s recent launch of the M14XL intermittent catheter, the longest available on the market today, is only the most recent example of how the company prioritizes end users.

Apacheta has master plan

Company seeks to synchronize more than just deliveries
 - 
08/19/2016

From June 2015 to June 2016, Springfield, Pa.-based Apacheta, a mobile workflow application that’s integrated with Brightree, experienced a 120% increase in customers, primarily HME providers.

ResMed under investigation

 - 
08/19/2016

SAN DIEGO – ResMed in July received a federal administrative subpoena from the Office of Inspector General requesting documents and other information related to its patient resupply software.

Drive Medical: ‘It is business as usual’

 - 
08/16/2016

PORT WASHINGTON, N.Y. – Drive Medical has sent a letter to its customers in response to reports that private equity firm Clayton, Dubilier & Rice is close to buying the company.

Inogen lines up strong 2016

 - 
08/12/2016

GOLETA, Calif. – The second quarter went so well for Inogen that the manufacturer and provider of portable oxygen concentrators has increased its guidance for the year.

Firm close to buying Drive, sources say

 - 
08/11/2016

PORT WASHINGTON, N.Y. – Buyout firm Clayton, Dubilier & Rice is in talks to buy Drive DeVilbiss for about $750 million, according to Reuters.

Change of focus drives improvements at Invacare

‘We are really not about the consent decree,’ top exec tells investors
 - 
08/05/2016

ELYRIA, Ohio – Invacare is holding tight to an improvement in gross margin for its beleaguered North America HME division as a sign that its turnaround efforts are paying off.

ResMed looks for growth in resupplies

‘I think there is a lot of runway (in that business),’ says top exec
 - 
08/05/2016

SAN DIEGO – ResMed invested $1 billion in acquisitions in fiscal year 2016. Now, the company is “laser focused” on getting a return on its investment, says CEO Mick Farrell.

Pages